SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11980329
Source:
http://linkedlifedata.com/resource/pubmed/id/11980329
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0022702
,
umls-concept:C0085559
,
umls-concept:C0205082
,
umls-concept:C0205195
,
umls-concept:C0343401
pubmed:issue
3
pubmed:dateCreated
2002-4-30
pubmed:abstractText
Vancomycin is always the drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in spite of his bactericidal kinetic.
pubmed:language
fre
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0265365
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cephalosporins
,
http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin
,
http://linkedlifedata.com/resource/pubmed/chemical/cefpirome
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0369-8114
pubmed:author
pubmed-author:AndrieuPP
,
pubmed-author:ArchambaudMM
,
pubmed-author:BonnelMM
,
pubmed-author:ChabanonGG
,
pubmed-author:ChaminadeBB
,
pubmed-author:ConilJ MJM
,
pubmed-author:CougotPP
,
pubmed-author:DecunJ FJF
,
pubmed-author:GeorgesBB
,
pubmed-author:HouinGG
,
pubmed-author:RocheCC
,
pubmed-author:SaivinSS
,
pubmed-author:SamiiKK
,
pubmed-author:VirenqueCC
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
161-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11980329-Adult
,
pubmed-meshheading:11980329-Aged
,
pubmed-meshheading:11980329-Bacteremia
,
pubmed-meshheading:11980329-Cephalosporins
,
pubmed-meshheading:11980329-Drug Therapy, Combination
,
pubmed-meshheading:11980329-Female
,
pubmed-meshheading:11980329-Humans
,
pubmed-meshheading:11980329-Intensive Care
,
pubmed-meshheading:11980329-Male
,
pubmed-meshheading:11980329-Methicillin Resistance
,
pubmed-meshheading:11980329-Middle Aged
,
pubmed-meshheading:11980329-Pneumonia, Bacterial
,
pubmed-meshheading:11980329-Prospective Studies
,
pubmed-meshheading:11980329-Staphylococcal Infections
,
pubmed-meshheading:11980329-Staphylococcus aureus
,
pubmed-meshheading:11980329-Treatment Outcome
,
pubmed-meshheading:11980329-Vancomycin
pubmed:year
2002
pubmed:articleTitle
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
pubmed:affiliation
Service de réanimation polyvalente, Pr Virenque, CHU Rangueil, 1, avenue Jean Pouilhes, 31403 Toulouse, France.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
English Abstract
,
Randomized Controlled Trial